The 2025 year in review
Advancements in drug therapies and a focus on the well-being of veterinary professionals were among the most viewed article topics on dvm360.com this year.
As 2025 draws to a close, dvm360 is reflecting on the veterinary industry news, clinical advancements, achievements in education, and more of the stories that had the most impact on our audience of veterinarians, veterinary technicians and nurses, customer service representatives, practice managers and administrators, pet owners, and other audience members.
Join us in looking back on the developments and memorable moments that contributed to the advancement of veterinary medicine in 2025. Read on for the Top 25 veterinary news articles of the year, from first to last, as determined by dvm360.com data collected from January 1, 2025, to November 1, 2025.
By Kristen Coppock Crossley, MA
Loyal’s developmental therapy aims to increase longevity and quality of life for senior dogs.
2. Veterinary school warns of severe feline illness following ingestion of oclacitinib chewable tablets
By Abi Bautista-Alejandre
Two cats who ingested the dog allergy medication experienced acute kidney injury and required 4 rounds of hemodialysis.
3. FDA notifies veterinarians of animal burn risk linked to human medical devices
By Abi Bautista-Alejandre
Dogs have experienced burn injuries following unsafe use of Megadyne grounding pads.
4. Lincoln Memorial University sues American Veterinary Medical Association
By Caitlin McCafferty
The university claims in its lawsuit that the AVMA is violating US antitrust laws.
5. First drug shown to reverse feline HCM expected to receive FDA approval
By Abi Bautista-Alejandre
The novel therapy is the first drug for treating cats with hypertrophic cardiomyopathy.
6. Tick tidbits: Ticking off the 5 W’s on these tiny troublemakers
By Kathryn E. Reif, PhD, MSPH; Sponsored by Elanco
Tick bite risks, prevention strategies, and treatments are reviewed.
7. Vetlen launches 5-mL pouch for targeted antibiotic therapy in animals
By Abi Bautista-Alejandre
The device received an FDA breakthrough device designation last year.
8. Veterinary visits decline as clients face rising costs, data reveal
By Abi Bautista-Alejandre
A white paper by Vetsource found that the time between client visits increased by 48% from 2023 to 2024 compared with 3 years ago.
9. Dry dog food supporting patients with atopic dermatitis is relaunched
By Abi Bautista-Alejandre
Skin Relief dry dog food by Rayne Nutrition is designed to help manage conditions such as atopic dermatitis, osteoarthritis, and more.
10. Relief practice allows veterinarians to thrive
By Kristen Coppock Crossley, MA
Temporary work is a choice that a growing number of doctors have made in recent years.
11. Kitten and puppy food are voluntarily recalled
By Kristen Coppock Crossley, MA
Certain Blue Ridge Beef products were found to be contaminated with bacteria that can cause illness in pets.
12. How urine albumin-to-creatinine ratio enhances CKD detection in dogs
By Ava Landry, PharmD candidate
Early diagnosis and treatment can help manage the disease and improve quality of life for affected patients.
13. The role of sustainability in pet food
By Miranda Morman, BS, PharmD candidate
A new study examined how large companies that produce meals for animals communicate their sustainability practices.
14. The rising costs of veterinary care: challenges and pathways to greater success
By Emily M. Tincher, DVM; sponsored by Nationwide
By helping pet families plan for costs, embracing a spectrum of care, and exploring innovative care models, veterinary teams can play a pivotal role in improving access to care for all pets.
15. Several cat deaths reported following bird flu exposure through raw pet food and milk
By Abi Bautista-Alejandre
Government officials are urging pet owners to avoid feeding pets raw diets amid multiple cases of highly pathogenic avian influenza in felines and raw pet food recalls.
16. Many pet owners cannot afford veterinary care, survey finds
By Abi Bautista-Alejandre
Nearly 1 in 3 pet parents says they know someone whose pet died because the owner could not afford the necessary treatment.
17. The case for year-round heartworm prevention and how to talk with clients about affordable options
By Peter C. Hann, DVM; sponsored by Aurora Pharmaceutical
Veterinary teams can help clients protect their pets from heartworm disease by offering compassionate guidance and affordable solutions, including safe and effective generic alternatives.
18. Drug label is updated for pain management therapy
By Kristen Coppock Crossley, MA
Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody for which real-world drug experience data have been collected in the past year.
19. Lyon College breaks ground on new veterinary school
By Kristen Coppock Crossley, MA
The animal health campus in Cabot, Arkansas, will feature more than 100,000 square feet of educational and clinical space.
20. FDA notifies veterinarians of adverse events linked to canine osteoarthritis treatment
By Abi Bautista-Alejandre
Neurologic signs were reported with bedinvetmab injection use in dogs.
21. New canine supplement is designed to improve muscle health
By Kristen Coppock Crossley, MA
At the 2025 Veterinary Meeting & Expo, Virbac launched an oral product featuring ursolic acid, in collaboration with Emmyon, Inc.
22. Practical weight loss in cats
By Mansum Yau, DVM
With these practical tips for cat weight loss, we can empower clients to help their cats achieve a normal body condition while maintaining, if not improving, the human-animal bond.
23. Kevin Costner at VMX 2025: Finding your heart
By Bob Alaburda
At the 2025 Veterinary Meeting & Expo, the movie star shared heartfelt stories about animals, purpose, and perseverance in an inspiring opening-day keynote address.
24. FDA conditionally approves first drug for feline subclinical hypertrophic cardiomyopathy
By Caitlin McCafferty
Felycin-CA1 manages ventricular hypertrophy in feline patients with subclinical hypertrophic cardiomyopathy.
25. FDA approves new canine otitis externa medication
By Caitlin McCafferty
Dechra’s Otiserene is a single-dose, long-acting product that utilizes marbofloxacin.